Megarectum in Adults (MEGA-ORIGINE)
Megarectum in Adults: Congenital or Acquired Pathology?
연구 개요
상태
상세 설명
The aim of this study is to identify and characterize elements of the clinical history, particularly early ones, associated with the disease, in order to contribute to the understanding of its pathophysiology.
To this end, the project aims to analyze the personal and family histories of patients with idiopathic bowel dysfunction (BD) and compare them with a population of constipated patients without BD, in order to determine the chronology of the onset of the condition (from birth, childhood/adolescence, or later) and to evaluate the risk factors for BD. It is also planned to describe the population of patients with BD to confirm whether or not different subgroups exist.
A better understanding of the pathophysiology of BD should make it possible to prevent the condition (if secondary to dyssynergia present in childhood) and/or to provide earlier, more appropriate management, thus avoiding acute episodes of bowel obstruction.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Vincent VF FERRANTI, ARC
- 전화번호: +33 02 32 88 82 65
- 이메일: Vincent.ferranti@chu-rouen.fr
연구 연락처 백업
- 이름: Nabila NL LAAJAIL, Director
- 전화번호: +33 02 32 88 82 65
- 이메일: nabila.laajail@chu-rouen.fr
연구 장소
-
-
-
Rouen, 프랑스, 76031
- Digestive Physiology Department
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
- Patients with idiopathic Mega-Rectum (MI) treated in the Digestive Physiology Department between 2016 and 2026 for the performance of a rectal barostat to confirm the megarectum suspected by anorectal manometry.
- Constipated patients recruited consecutively during consultations by physicians in the Digestive Physiology department, and whose anorectal manometry, performed as part of routine care, ruled out the diagnosis of megarectum
설명
Inclusion Criteria:
- Idiopathic megarectum (IM) group:
- Adult patients presenting with chronic constipation according to the Rome criteria;
- Patients with megarectum suspected by anorectal manometry and confirmed by rectal barostat;
- Isolated, idiopathic megarectum (no known cause);
Constipated group:
- Constipated adult patients presenting consecutively with chronic functional constipation according to the Rome criteria;
- Patients without megarectum suspected by anorectal manometry.
Exclusion Criteria:
- Patients who are not constipated;
- Hirschsprung's disease;
- Patients with anorectal malformation;
- Patients with known neurological conditions;
- Patients with endocrine disorders that may cause constipation;
- Patients taking constipating medications such as morphine or neuroleptics;
- Patients with a potential organic and/or drug-induced cause of constipation;
- Constipation secondary to medication;
- Patients unable to complete a questionnaire;
- Patients deprived of their liberty, under guardianship, or curatorship
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
To determine if patients with Idiopathic MegaRectum (MI) have a history of earlier constipation in childhood than constipated patients without megarectum
기간: 1 day
|
This involves comparing the history of constipation that may reveal anorectal dysfunction in childhood in constipated adults with MI and in constipated control subjects without megarectum through clinical questioning.
|
1 day
|
|
To determine if patients with Idiopathic MegaRectum (MI) have a history of more digestive symptoms in childhood than constipated patients without megarectum
기간: 1 day
|
This involves comparing the history of digestive symptoms that may reveal anorectal dysfunction in childhood in constipated adults with MI and in constipated control subjects without megarectum through clinical questioning.
|
1 day
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Comparison of environmental factors in constipated adults with MI and in constipated control subjects without megarectum
기간: 1 day
|
Determination of the presence of environmental factors in childhood: breastfeeding, repeated early antibiotic therapy, drug treatment in childhood and indication (antibiotics, anticholinergic treatments, opiates, morphine, etc.) through clinical questioning
|
1 day
|
|
Comparison of environmental factors in constipated adults with MI and in constipated control subjects without megarectum
기간: 1 day
|
Presence of psychosocial factors in childhood: psychosocial or school-related stress, anxiety and depressive disorders as revealed by clinical questioning
|
1 day
|
|
megarectum phenotyping
기간: 1 day
|
The aim is to phenotype the megarectum using anorectal manometry to distinguish an "acquired" profile from a "congenital" profile.
The measured indicators will be anal tone, amplitude and duration of voluntary contraction, the presence of the rectoanal inhibitory reflex; the amplitude of the rectoanal inhibitory reflex at 30 ml of rectal distension; the presence of rectosphincter dyssynergia; the amplitude of rectal contraction during straining; the percentage of anal relaxation during straining; the residual pressure during straining; the threshold volume for perceiving rectal distension; the constant perceiving volume; the maximum tolerable volume; and rectal compliance.
|
1 day
|
|
megarectum phenotyping
기간: 1 day
|
The aim is to phenotype the megarectum using Balloon evacuation test is to assess a patient's ability to evacuate stools, particularly in cases of constipation or suspected defecation disorder. This test is based on the concept of success or failure. Success: The patient manages to expel the balloon within a timeframe considered normal (often < 1 to 2 minutes, according to protocols). This suggests that the recto-anal evacuation mechanism is generally functioning correctly. Failure: The patient is unable to expel the balloon or takes an abnormally long time. This may indicate a defecation disorder, for example: anorectal dyssynergia (poor muscle coordination), rectal hypocontractility, or a functional obstruction to evacuation. |
1 day
|
|
megarectum phenotyping
기간: 1 day
|
The aim is to phenotype the megarectum using rectal Barostat is to allow the measurement of rectal distension volumes to obtain the desired rectal pressure
|
1 day
|
|
megarectum phenotyping
기간: 1 day
|
The aim is to phenotype the megarectum using rectal Barostat is to allow the measurement of rectal distension volumes to obtain the rectal compliance
|
1 day
|
|
megarectum phenotyping
기간: 1 day
|
The aim is to phenotype the megarectum using rectal Barostat is to allow the measurement of rectal distension volumes to obtain the maximum tolerable volume;
|
1 day
|
|
megarectum phenotyping
기간: 1 day
|
The aim is to phenotype the megarectum using imagery is to assess rectal size in diameter
|
1 day
|
|
megarectum phenotyping
기간: 1 day
|
The aim is to phenotype the megarectum using imagery is to assess colon size in diameter
|
1 day
|
|
Constipation Severity Score Evaluation
기간: 1 day
|
This assessment is carried out using the Kess scores. The KESS score (KESS score = Knowles-Eccersley-Scott Symptom score) is intended to assess the severity of chronic constipation. It takes into account: frequency of bowel movements; difficulty passing stool; feeling of incomplete evacuation; use of laxatives; pain or straining; duration of the problem. The higher the score, the more severe the constipation. |
1 day
|
|
Constipation Severity Score Evaluation
기간: 1 day
|
This assessment is carried out using the Francis scores. The Francis score (or IBS-SSS: Irritable Bowel Syndrome Severity Scoring System) is used to measure the severity of Irritable Bowel Syndrome. It assesses: intensity of abdominal pain; frequency of pain; bloating/distension; bowel movement irregularities; and impact on quality of life. The total score ranges from 0 to 500: < 75: no or very mild symptoms; 75-175: mild; 175-300: moderate; 300: severe. |
1 day
|
|
fecal incontinence severity score
기간: 1 day
|
The Cleveland Clinic score will be used to assess the severity of chronic constipation. This score assesses several factors: frequency of bowel movements; difficulty of defecation; straining; feeling of incomplete evacuation; abdominal pain; time spent on the toilet; need for assistance (laxatives, enemas, digital defecation); duration of constipation. Each item is assigned a number of points. In practice: < 8: mild constipation; 8-15: moderate constipation; > 5: severe constipation |
1 day
|
|
Quality of life score assessment
기간: 1 day
|
The quality of life score will be assessed using the GIQLI questionnaires. The GIQLI (Gastrointestinal Quality of Life Index) is a questionnaire used to measure quality of life related to digestive diseases. The questionnaire comprises 36 questions. Each question is scored from 0 to 4 on the following scale: 0 = very poor condition / significant symptoms 4 = no problems The maximum score is 144. A high score indicates good digestive health. A low score indicates significant impact of digestive disease. |
1 day
|
|
Quality of life score assessment
기간: 1 day
|
The quality of life score will be assessed using the PAC-QOL questionnaire. The PAC-QOL (Patient Assessment of Constipation - Quality Of Life) is a specific questionnaire used to assess the impact of chronic constipation on quality of life.The questionnaire typically contains 28 questions divided into several areas: 1) physical discomfort; 2) psychosocial discomfort; 3) worries/concerns; 4) satisfaction. Each item is rated on a scale of 0 to 4. A low score indicates a good quality of life; A high score indicates a significant impact of constipation. |
1 day
|
|
Quality of life score assessment
기간: 1 day
|
The quality of life score will be assessed using the FIQL questionnaires. The FIQL (Fecal Incontinence Quality of Life Scale) is a questionnaire designed to assess the impact of fecal incontinence on quality of life. The FIQL measures the psychological, social, and emotional impact of fecal incontinence, going beyond simply the frequency of leakage. It explores, in particular: social discomfort; anxiety; self-image; limitations in daily activities; emotional impact. The FIQL comprises 29 questions divided into 4 domains: 1) Lifestyle; 2) Behavior; 3) Depression/Self-Perception; 4) Embarrassment. Each question is scored on a scale of 0 to 4. A high FIQL indicates a better quality of life. A low FIQL indicates a significant impact of incontinence. |
1 day
|
|
Predictive factors for each of these profiles in terms of medical history
기간: 1 day
|
Identify predictive factors for each of these profiles in terms of family history during the clinical interview with the patient (severe constipation leading to surgery (and type of surgery) or difficult to treat medically, onset of constipation in childhood or adulthood, Hirschsprung's disease, colonic inertia, chronic intestinal pseudo-obstruction, gastroparesis, stoma, gastrostomy, enteral or parenteral nutrition, anorectal malformation, neurological malformation)
|
1 day
|
|
Predictive factors for each of these profiles in terms of medical history
기간: 1 day
|
Identify the predictive factors of each of these profiles in terms of personal history during the clinical interview with the patient (severe constipation requiring surgical intervention (and type of intervention) or difficult to treat medically, onset of constipation in childhood or adulthood, Hirschsprung's disease, colonic inertia, chronic intestinal pseudo-obstruction, gastroparesis, stoma, gastrostomy, enteral or parenteral nutrition, anorectal malformation, neurological malformation).
|
1 day
|
|
Current symptoms
기간: 1 day
|
Identify current symptoms: encopresis, fecal incontinence, dyschezia, abdominal bloating, abdominal pain, number of bowel movements per week, stool consistency according to the Bristol Stool Scale
|
1 day
|
|
Predictive factors for each of these profiles in terms of medical history
기간: 1 day
|
information search regarding the age of toilet training in childhood during the clinical interview with the patient.
|
1 day
|
|
Predictive factors for each of these profiles in terms of medical history
기간: 1 day
|
information search regarding childhood digestive symptoms during the clinical interview with the patient.
|
1 day
|
|
Predictive factors for each of these profiles in terms of medical history
기간: 1 day
|
information regarding stool frequency in childhood and stool consistency in childhood during the clinical interview with the patient.
|
1 day
|
|
Predictive factors for each of these profiles in terms of medical history
기간: 1 day
|
research for information regarding the factors identified as triggers of constipation during the clinical interview with the patient.
|
1 day
|
|
Predictive factors for each of these profiles in terms of medical history
기간: 1 day
|
information search regarding possible pain during defecation during the clinical interview with the patient.
|
1 day
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Anne-Marie AL LEROI, Professor, University Rouen Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2026/0116/OB
- 2026-A00636-45 (기타 식별자: ANSM)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .